Results 151 to 160 of about 75,548 (336)
Therapeutic targeting of chromatin alterations in leukemia and solid tumors
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner+7 more
wiley +1 more source
The role of UPR‐related long noncoding RNAs in development of endocrine resistance in breast cancer
Abstract Breast cancer patients who express estrogen receptor α (ER) typically receive endocrine therapy as a first‐line treatment. Most ER‐positive breast cancer patients initially respond to endocrine therapy, but up to 40% of patients develop resistance over time, and the main mechanism is aberrant activation of ER signaling pathways.
Wen Liu, Sahil Gupta, Sanjeev Gupta
wiley +1 more source
What's New? Lynch syndrome is a prevalent cause of hereditary gynecological cancers, but the timeline of molecular alterations preceding malignancy remains unclear. By studying consecutive surveillance specimens for up to 15 years before cancer diagnosis, the authors found that atypical endometrial hyperplasia was indistinguishable from endometrial and
Anni K. Kauppinen+3 more
wiley +1 more source
Pembrolizumab in programmed death ligand 1-positive endometrial cancer [PDF]
BENEDETTI PANICI, Pierluigi+2 more
core +1 more source
What's New? Current knowledge of the genetic architecture underlying the development of renal cell carcinoma‐related multiple primary tumours is limited. The authors comprehensively analysed the results of exome/genome sequencing cohorts including 534 patients to better define genotype–phenotype correlations.
Huairen Zhang+6 more
wiley +1 more source
The Value of DNA Quantitative Cytology Test for the Screening of Endometrial Cancer
Bao-hua Yang,1 Ming-xia Yu,1 Jun Xu,1 Yan Su,1 Zhi-hong Ai2 1Department of Obstetrics and Gynecology, Shanghai Minhang Central Hospital, Shanghai 201199, People’s Republic of China; 2Department of Obstetrics and Gynecology, Shanghai Jiao Tong ...
Yang B, Yu M, Xu J, Su Y, Ai Z
doaj
Integrative omics approaches to uncover liquid‐based cancer‐predicting biomarkers in Lynch syndrome
What's New? Lynch syndrome (LS) significantly increases lifetime cancer risk, necessitating innovative approaches for risk stratification. Current risk assessment methods, however, fail to integrate data from different biological systems, which may be influenced by lifestyle factors.
Minta Kärkkäinen+9 more
wiley +1 more source
Abstract Objective In the present study, a bidirectional two‐sample Mendelian randomization approach was utilized to explore potential causal relationships between mitochondrial DNA copy number (mtDNA‐CN) and ovary‐related reproductive disorders (ORRDs), including ovarian dysfunction, ovarian cyst, polycystic ovary syndrome (PCOS), premature ovarian ...
Ke Peng+4 more
wiley +1 more source
Malignant mixed Müllerian tumor
Uterine carcinosarcomas or malignant mixed Müllerian tumors are rare neoplasms. They have an aggressive behavior and the prognosis depends mainly on the stage of the disease at the time of diagnosis. The progression of these tumors is unfavorable despite
Javier Martínez-Navarro+2 more
doaj
Abstract Objective To evaluate if structured reports (SR) of pelvic magnetic resonance imaging (MRI) scans using the PALM‐COEIN FIGO (the International Federation of Gynecology & Obstetrics) uterine leiomyomas classification (SR‐FIGO) contain adequate information for clinical decision making compared with narrative reports (NR). Methods Three reporting
Laura Tordjman+8 more
wiley +1 more source